Oxford Biomedica completes €68m sale & leaseback of Windrush Court

UK-based gene and cell therapy group Oxford Biomedica has sold its Windrush Court facility in Oxford to Kadans Science Partner for £60 mln (€68 mln).

Premium subscriber content – please log in to read more or take a free trial.


Latest news

Best read stories